Breast MRI can have both high sensitivity and specificity for cancer detection but also poses challenges. Specificity may be around 70-90% depending on the population and comparison to mammography. Sensitivity also varies based on the gold standard used, ranging from over 95% in many studies to around 75% for screening studies. Both false positives and false negatives can occur for reasons such as artifacts, normal breast tissue, benign lesions, tumor characteristics like size, and interpretation errors. The document provides guidance on analyzing lesions, potential pitfalls, and ways to improve accuracy such as recognizing pseudo-enhancement, accounting for clinical context, and recommending appropriate follow up.